JP Stock MarketDetailed Quotes

4502 Takeda Pharmaceutical

Watchlist
  • 4391.0
  • +12.0+0.27%
20min DelayMarket Closed Aug 23 15:00 JST
6.99TMarket Cap48.17P/E (Static)

Takeda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Takeda Pharmaceutical Q1 2025 Earnings Date

Currency：JPYJul 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.08T
1.21T
+126.69B
Beat Est.
+2.14%
+14.11%
+11.72%
EPS
--
29.97
--
+4.94%
Analyst Rating
Buy

Aug 22, 2024

Takeda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.163T--
Oct 31, 20242025/Q2-- / 1.070T--
Jul 31, 20242025/Q11.208T / 1.081T--
May 9, 20242024/Q41.051T / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.163T--
Oct 31, 20242025/Q2-- / 1.070T--
Jul 31, 20242025/Q11.208T / 1.081T--
May 9, 20242024/Q41.051T / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--

Unlock Free Earnings Estimates

Takeda Pharmaceutical Earnings Reports

  • Takeda Pharmaceutical: First quarter financial report for the March 2025 period (IFRS) (consolidated).

    Jul 31 02:00 ET

  • Takeda Pharmaceutical: Extraordinary Report

    Jul 1 22:53 ET

  • Takeda Pharmaceutical: Confirmatory letter.

    Jun 26 03:02 ET

  • Takeda Pharmaceutical: Financial Report - 147th Term (2023/04/01 - 2024/03/31)

    Jun 26 03:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 22, 2024

    Buy

    • Strong Buy

      38.89%

    • Buy

      11.11%

    • Hold

      50.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg